Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.

byiShook Opinion
Dec 20, 2024 - 09:40

Share

Novo Nordisk stock crashed Friday after the Danish giant reported its experimental obesity drug CagriSegma missed goals. Eli Lilly and Viking Therapeutics jumped The post Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump. appeared first on Investor's Business Daily.

Novo Nordisk stock crashed Friday after the Danish giant reported its experimental obesity drug CagriSegma missed goals. Eli Lilly and Viking Therapeutics jumped

The post Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump. appeared first on Investor's Business Daily.